glp-1 intestinal paralysis law office in louisiana constipation Attorney Jonathan Orent joins NewsNation to discuss the wrongful death lawsuit filed against Novo Nordisk semaglutide digestive blockage law firm

For continuation versus noncontinuation, the weighted prevalence ratios were 1.29 (95 percent confidence interval, 0.82 to 2.06), 1.08 (95 percent confidence interval, 0.84 to 1.40), and 1.21 (95 percent confidence interval, 0.83 to 1.82) for small for gestational age, large for gestational age, and MCM, respectively."Accumulated evidence provides some reassurance about risk for malformations after inadvertent exposure in women who become pregnant while using GLP-1 RAs," the authors write.Abstract/Full Text (subscription or payment may be required).Sign up for our weekly HealthDay newsletter

PMID: 27601965

10.1007/s12975-022-01096-3 510 ZhangY.DongY.LuP.WangX.LiW.DongH.et al

Nature 633 , 758760 (2024)